AMRX - AMNEAL INVESTIGATION NOTICE: Kaskela Law LLC Announces Shareholder Investigation of Amneal Pharmaceuticals Inc. (NYSE: AMRX) and Encourages Investors with Losses to Contact the Firm | Benzinga
PHILADELPHIA, Dec. 27, 2023 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating Amneal Pharmaceuticals, Inc. (NYSE:AMRX) ("Amneal") on behalf of the Company's shareholders.
Since March 2019, shares of Amneal's common stock have declined in value from over $14.00 per share to a current trading price of below $6.00 per share, a cumulative decline of over 57% in value.
The investigation seeks to ...
AMRX) and Encourages Investors with Losses to Contact the Firm>Full story available on Benzinga.com